Avalon Technologies Q2: Sustaining the Blitz
The EMS growth engine delivered ₹484.4 Cr in Q1 FY27 with PAT leaping 145% YoY. Q2 will test whether the momentum holds—and whether management's uplifted FY27 guidance (26–30% growth) is durable as new JVs and facilities come online.
The Setup: A Blitzkrieg in EMS, Questions on Margin Stickiness
Avalon Technologies has spent FY26–FY27 building a global EMS franchise, and it shows. Q1 FY27 delivered ₹484.4 Cr in revenue (up 49.8% YoY) and PAT of ₹34.9 Cr (up 145.3% YoY)—the company's highest-ever quarterly numbers. The real story is not the top-line blitz but the order book hitting ₹2,016 Cr (26.5% YoY growth), with ₹1,183 Cr in long-term contracts cementing demand visibility. For Q2, expectations center on whether gross margins—guided at 33–35% for the year—hold steady amid scale-up of new facilities (Oragadam, SIPCOT) and the Zollner JV ramp.
~₹430–480 Cr
In-line with H1 trajectory; order book strength underpins sequentiality. Sequential growth of ~0–5% typical given seasonal patterns in EMS.
~33–35%
FY27 guided range; Q1 tracked within band. Watch for facility ramp-up drag and mix shift toward higher-margin ETO work.
~6.5–7.5%
Q1 achieved 7.2% (₹34.9 Cr / ₹484.4 Cr). Guidance revisions higher by analysts suggest confidence in operating leverage.
₹1,183 Cr+
The flywheel: visible demand reduces execution risk and supports margin predictability across cycles.
What a strong Q2 looks like: Revenue ₹470+ Cr with gross margins ≥34% and PAT margin ≥7.0%; management commentary on Zollner ramp timeline and Oragadam facility utilization; order book update >₹2,000 Cr showing stickiness. What a weak Q2 looks like: Revenue miss <₹420 Cr or gross margin contraction to <32%; guidance cut or pause on new facility/JV capex; order book stalling or major customer loss flagged.
Tracking the Full-Year Guide
In October, management lifted FY27 revenue guidance to 26–30% growth from 24–27%, implying confidence in the order book and execution. At ₹484.4 Cr in Q1, a 26–30% full-year growth requires ~₹350–380 Cr in H2 normalized run-rate (assuming modest seasonal decline in Q3/Q4 typical for EMS). Q2 will be the first test: if revenue trends toward the ₹470+ Cr zone, the guide credibility firms; if it dips sharply, the Street will re-rate guidance as binary risk. Analyst consensus, despite strong fundamentals, has 4 Sell ratings among 15 watchers—suggesting valuation skepticism rather than operation doubt.
Since Last Quarter: Zollner JV Live, ₹425 Cr Warrant Issuance, Promoter Shift
1 · Zollner JV Incorporation (Oct 19)
Wholly owned subsidiary Zollner Avalon Private Limited incorporated; Zollner Elektronik AG to subscribe for equity. JV focused on PCBA, box-build, and system integration in India—a capex-light way to scale globally-contracted volume. Watch for: capex committed, timeline to first revenue, margin structure.
2 · ₹425 Cr Warrant Issuance (Oct 27)
Board approved preferential issuance of 19.37 lakh warrants @ ₹2,193.20 each. Likely vehicle for capital raise without immediate dilution; exercise dynamics and use-of-proceeds (capex, JV funding, M&A) to be revealed on result day.
3 · SIPCOT Facility Lease (Oct 8)
Leased 25.08 acres in Oragadam, Tamil Nadu (SIPCOT park). Second large facility addition signals confidence in order-book durability and geographic diversity. Ramp timeline critical: capex drag in Q2–Q3, upside from utilization in Q4–H1 FY28.
4 · Promoter Reclassification Request (Nov 3)
Bhaskar Srinivasan (promoter) and associated trusts seek reclassification from Promoter to Public shareholder. Follows the Oct 1 sale of 6.0% stake (40.08 L shares @ ₹2,527.69). Promoter holding now ~38.4% (from 44.4% a year ago). Routine reorganization or early-stage family office restructure—flag for capital structure questions on the call.
5 · EGM Scheduled (Nov 21)
Extra-Ordinary General Meeting on Nov 21 to approve warrant terms and other corporate actions. No immediate result impact, but timing (post-result call) allows management to address any Q2 miss or capex concerns live.
Three Things to Watch on Result Day
1. Gross margin stickiness under scale: Q1 HIT 33–35% guided range; Q2 will show if new facility ramp and Zollner pre-revenue costs erode it. A margin band <32% would undermine the FY27 guide and trigger valuation reset. 2. Order book trajectory and forward visibility: Expected update on total order book (H1 guidance, ₹2,000+ Cr bar) and mix of long-term vs project business. Geographic and vertical breakout (automotive, industrial, aerospace, consumer) for US exposure clarity. 3. Zollner & Oragadam capex, timeline, and margin roadmap: Net capex guidance for FY27 and payback horizon critical. Management commentary on whether Zollner contributes EBITDA in FY28 or remains pre-revenue through FY27 will reset Street estimates and valuation multiple.
Avalon Technologies stands at an inflection: the order book is full, guidance has been lifted, and the Street's own EPS models are creeping higher—yet the stock trades 24% below consensus target and sits -27.6% from highs. Q2 results will clarify whether the August-to-September momentum in FY27 (Q1's stellar delivery) is repeatable or cyclical. A solid print (₹450+ Cr, margin ≥33%, PAT ≥6.5%) with bullish forward signals (order book >₹2,100 Cr, Zollner ramp, capex roadmap) would validate the lift in guidance and pressure bears; a miss or margin decay would prove the skeptics right. The new 25-acre facility and Zollner JV are the company's biggest structural bets in two years—how well management threads the capex-without-margin-drag story will define the next 12 months.
Avalon Q2 FY27: Consolidated PAT Up 59% YoY, Revenue +37%, NPM Expands to 7.6%
PAT +59.48% YoY · revenue +37.4% · margins expanding · beat vs street
₹525.43 Cr
+37.4% YoY
₹39.84 Cr
+59.48% YoY
7.54%
+1.1pp YoY
₹5.96
Avalon Technologies' consolidated Q2 FY27 revenue came in at ₹525.4 Cr, up 37.4% YoY and 8.5% QoQ, with consolidated PAT of ₹39.84 Cr, up 59.5% YoY and 14.2% QoQ — EPS of ₹5.96 against ₹3.73 a year ago. Net profit margin expanded to 7.58% from 6.40% YoY-ago and 7.16% last quarter, continuing a three-quarter expansion trend; EBITDA margin (OPM) also moved up to roughly 13.1% from about 10.1% YoY-ago. Both revenue and the margin trajectory land at or above the top of the on-plan range we flagged pre-result (₹430-480 Cr revenue, 6.5-7.5% PAT margin), and the 37.4% YoY revenue print clears even the FY27 growth guidance that management raised to 26-30% after Q1 (from the 24-27% guided at the Q4 FY26 call) — a clear beat on both guidance and the pre-result street read, which had been cautious on valuation (median target ₹1,350 against a Nov 6 close of ₹1,893.6) even as FY27/FY28 EPS estimates were being raised.
Q2 FY-2027 vs prior quarters
The margin bridge is not evenly split across the group, though: standalone PBT and PAT both fell year-on-year (PAT ₹21.02 Cr vs ₹24.76 Cr, -15.1%) even as standalone revenue grew 23.9% to ₹255.6 Cr — cost of raw materials and other expenses outpaced revenue at the India entity. That means essentially all of the consolidated profit outperformance this quarter came from subsidiaries, consistent with management's prior commentary that the capex-light EMS model and the U.S. operations (ABV Electronics/Sienna Corporation) were progressing toward breakeven; this is a >3% divergence between standalone and consolidated growth stories, worth flagging since readers comparing the two tables will otherwise see what looks like a contradiction.
The stock went into the print at ₹2,043.8, down 10.5% over the past month of trading.
For context: this is the second-highest quarterly PAT of the last 6 quarters; revenue is at a 6-quarter high.
Management guides for 24-27% revenue growth in FY27, with an ambitious long-term goal to double revenue again to approximately INR 3,200 crores by FY29 from its FY26 base. Gross margins are expected to hold within the 33-35% range, with overall profitability set to improve through operating leverage as the U.S. operati
— This quarter: beat
Several board actions this quarter tie directly into the subsidiary-driven story: a ₹55 Cr corporate guarantee for wholly-owned Avalon Technology and Services, a ₹50.5 Cr guarantee for U.S. unit ABV Electronics, and an ₹11 Cr convertible-note investment for a 2.26% stake in Singapore's Revos Auto Tech (EV charging infrastructure) were all approved at the same meeting. Two watch items we flagged pre-result were also confirmed in the filing's notes: the Zollner Avalon JV (51:49 with Zollner Elektronik AG, for PCBA/box-build/system integration) was incorporated on October 19, 2026, and the ₹425 Cr preferential warrant issue (19.37 lakh warrants at ₹2,193.20 each) to Zollner Elektronik AG was approved October 27 and now awaits shareholder sign-off. Separately, promoter Bhaskar Srinivasan and family trusts (9.42% combined holding) had their request to reclassify from Promoter to Public category approved, subject to regulatory approvals. Management's own release framed the quarter as "Revenue Up 37.4% YoY" with a bullish outlook; the numbers agree on the topline but understate that the India standalone business's profitability actually contracted this quarter.
W1
Zollner Avalon JV ramp — watch standalone order flow/revenue contribution once the newly incorporated JV becomes operational.
W2
₹425 Cr warrant issue to Zollner Elektronik AG (19.37 lakh warrants, ₹2,193.20 each) — pending shareholder approval; watch dilution and stated use of proceeds.
W3
US subsidiary (ABV Electronics/Sienna Corp) path to breakeven management guided for 'late FY27' — watch whether standalone-consolidated profit gap narrows next quarter.